Search

Displaying results 3571 - 3580 of 10000 in total
  1. Drug

    Coagulation factor X human

    go.drugbank.com/drugs/DB13148
    ApprovedInvestigational

    Inherited factor X deficiency is a rare autosomal recessive bleeding disorder that is estimated to occur in 1:1 000 000 individuals up to 1:500 carriers [A31471]. … However its use is limited in the perioperative setting for the management of bleeding in major surgery in patients with moderate and severe hereditary Factor X deficiency.

    Mixtures: UMAN COMPLEX, UMAN COMPLEX
  2. Drug

    Tocofibrate

    go.drugbank.com/drugs/DB19752
    Experimental

    The usage of the INN stem '-fibrate' in the name indicates that Tocofibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Tocofibrate is a small molecule drug.

  3. Drug

    Pirifibrate

    go.drugbank.com/drugs/DB20620
    Experimental

    The usage of the INN stem '-fibrate' in the name indicates that Pirifibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Pirifibrate is a small molecule drug.

  4. Drug

    Salafibrate

    go.drugbank.com/drugs/DB20767
    Experimental

    The usage of the INN stem '-fibrate' in the name indicates that Salafibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Salafibrate is a small molecule drug.

  5. Drug

    Nicofibrate

    go.drugbank.com/drugs/DB19916
    Experimental

    The usage of the INN stem '-fibrate' in the name indicates that Nicofibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Nicofibrate is a small molecule drug.

  6. Drug

    Dulofibrate

    go.drugbank.com/drugs/DB20032
    Experimental

    The usage of the INN stem '-fibrate' in the name indicates that Dulofibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Dulofibrate is a small molecule drug.

  7. Drug

    Elarofiban anhydrous

    go.drugbank.com/drugs/DB21212
    Experimental

    The usage of the INN stem '-fiban' in the name indicates that Elarofiban anhydrous is a fibrinogen receptor antagonist (glycoprotein IIb/IIIa receptor antagonist). … Elarofiban anhydrous is a small molecule drug.

  8. Drug

    Lifibrate

    go.drugbank.com/drugs/DB21399
    Experimental

    The usage of the INN stem '-fibrate' in the name indicates that Lifibrate is a clofibrate derivative, peroxisome proliferator activated receptor-a (PPAR-a) agonist. … Lifibrate is a small molecule drug.

  9. Drug

    Satralizumab

    go.drugbank.com/drugs/DB15762
    ApprovedInvestigational

    [A218551] It received subsequent approvals in Switzerland and Japan,[A218551] and was approved for use by the FDA in August 2020,[L15566] becoming the 3rd treatment to receive FDA approval for NMOSD (after … Satralizumab was first approved for use in Canada in June 2020 for the treatment of AQP4 antibody-positive patients with NMOSD.

  10. Drug

    Artemether

    go.drugbank.com/drugs/DB06697
    ApprovedInvestigational

    Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy.

    Synonyms: (1R,4S,5R,8S,9R,10S,12R,13R)-10-methoxy-1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.0^{4,13}.0^{8,13}]hexadecane, 10-methoxy-1,5,9-trimethyl-(1R,4S,5R,8S,9R,10S,12R,13R)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecane